#bahtbag.com

[bahtbag]

OPEC + decided to maintain an increase of 400000 barrels per day per month, and US oil remained above US $68

On Wednesday (September 1), US oil futures rose US $0.09 to settle at US $68.59/barrel; Cloth oil fell US $0.04 to close at US $71.59/barrel. Earlier in the session, the oil distribution was as low as $70.42/barrel, and the US oil was as low as $67.12/barrel. After a short video conference, OPEC + agreed to abide by the existing schedule of gradual monthly production increase, which is in sharp contrast to the difficult negotiations in July, which is a gratifying phenomenon for the market. Meanwhile, EIA data showed that as of the week of August 27, crude oil inventories had decreased significantly by 7.169 million barrels, much more than expected, providing a bullish signal for oil prices.

https://www.bahtbag.com/futures/opec-decided-to-maintain-an-increase-of-400000-barrels-per-day-per-month-and-us-oil-remained-above-us-68/

[bahtbag]

Now is a good time to invest in Japanese stocks

As the Nikkei 225 Index stands at the 30,000-point mark, JPMorgan Chase said the recent political turmoil in Japan provides a good time for foreign investors to buy Japanese stocks without hedging the exchange rate.

On Wednesday, the Nikkei 225 continued to rise, closing up 0.9% at 30,181.21 points, up 8 days in a row and standing at the 30,000-point mark. Earlier, according to CNN, Japanese Prime Minister Kan Yoshihide held a press conference on the 3rd and announced that he would not run for the LDP presidential election. With Kan’s “sudden abstention”, the LDP is scheduled to formally announce the election of the president on the 17th of this month, and vote for a new president on the 29th.

[bahtbag]

Moderna stock extends rally after price target gets a 77% boost at Morgan Stanley

Shares of Moderna Inc. rallied toward a fifth straight gain Tuesday, after Morgan Stanley analyst Matthew Harrison added nearly $150 to his price target on an increased outlook for the biotechnology company’s COVID-19 vaccine sales.

Meanwhile, he downgraded several other biopharma stocks, including those of COVID-19 vaccine producer Johnson & Johnson JNJ, -1.55%, citing valuation concerns, of Merck & Co. Inc. MRK, -1.66% given lack of potential upside catalysts and of Amgen Inc. AMGN, -2.22% on valuation. All three of those stocks are Dow Jones Industrial Average DJIA, -0.76% components.

[bahtbag]

Semiconductor maker Axcelis beats revenue, estimates to 17-year high, global semiconductor sales up 29% in July

After a dull July, semiconductor stock Axcelis Technologies (NSDAQ: ACLS) regained investor attention in August, rising 28.9 percent in August, according to S&P Global Market Intelligence. The reason for the company’s share price rise was partly related to the global semiconductor chip shortage and partly from the company’s second-quarter financial data released in August.